Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera
Open Access
- 28 September 2006
- journal article
- Published by Springer Nature in Leukemia
- Vol. 20 (12) , 2210-2211
- https://doi.org/10.1038/sj.leu.2404419
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia veraBlood, 2006
- Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627ELeukemia, 2006
- Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disordersLeukemia, 2005
- Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersBlood, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disordersBlood Reviews, 2005
- Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase DomainMolecular Biology of the Cell, 2003